LIFECORE BIOMEDICAL, INC. Preferred Stock Convertible Shares Issuable
LIFECORE BIOMEDICAL, INC. (LFCR) had Preferred Stock Convertible Shares Issuable of 7.68 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Equity › Stockholders' Equity Note › Features of Convertible Preferred Stock
us-gaap:PreferredStockConvertibleSharesIssuable · last filed 2026-08-05
- 2026-06-30: Preferred Stock Convertible Shares Issuable 7.68M shares.
- 2026-03-31: Preferred Stock Convertible Shares Issuable 7.54M shares.
- 2025-12-31: Preferred Stock Convertible Shares Issuable 7.40M shares.
- 2025-09-30: Preferred Stock Convertible Shares Issuable 7.13M shares.
| Period end | Preferred Stock Convertible Shares Issuable |
|---|---|
| 2026-06-30 | 7.68M shares 10-Q · filed 2026-08-05 |
| 2026-03-31 | 7.54M shares 10-Q · filed 2026-05-06 |
| 2025-12-31 | 7.40M shares 10-KT · filed 2026-03-16 |
| 2025-09-30 | 7.13M shares 10-Q · filed 2025-11-06 |
| 2025-05-25 | 7.00M shares 10-K · filed 2025-08-07 |
| 2025-02-23 | 6.06M shares 10-Q · filed 2025-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |